
Dermapharm Holding SE
XETRA:DMP

Intrinsic Value
The intrinsic value of one
DMP
stock under the Base Case scenario is
44.25
EUR.
Compared to the current market price of 39.55 EUR,
Dermapharm Holding SE
is
Undervalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Dermapharm Holding SE
Fundamental Analysis


Revenue & Expenses Breakdown
Dermapharm Holding SE
Balance Sheet Decomposition
Dermapharm Holding SE
Current Assets | 593.5m |
Cash & Short-Term Investments | 124.8m |
Receivables | 102.1m |
Other Current Assets | 366.7m |
Non-Current Assets | 1.5B |
Long-Term Investments | 82.8m |
PP&E | 315m |
Intangibles | 1.1B |
Other Non-Current Assets | -1k |
Free Cash Flow Analysis
Dermapharm Holding SE
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Dermapharm Holding SE
Revenue
|
1.2B
EUR
|
Cost of Revenue
|
-413.7m
EUR
|
Gross Profit
|
767.1m
EUR
|
Operating Expenses
|
-539.3m
EUR
|
Operating Income
|
227.8m
EUR
|
Other Expenses
|
-114m
EUR
|
Net Income
|
113.8m
EUR
|
DMP Profitability Score
Profitability Due Diligence
Dermapharm Holding SE's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Score
Dermapharm Holding SE's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
DMP Solvency Score
Solvency Due Diligence
Dermapharm Holding SE's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Score
Dermapharm Holding SE's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DMP Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for
DMP
is 47.43 EUR
with a low forecast of 44.44 EUR and a high forecast of 51.45 EUR.
Dividends
Current shareholder yield for DMP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
DMP
stock under the Base Case scenario is
44.25
EUR.
Compared to the current market price of 39.55 EUR,
Dermapharm Holding SE
is
Undervalued by 11%.